Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 464

1.

Diabetes-mediated promotion of colon mucosa carcinogenesis is associated with mitochondrial dysfunction.

Del Puerto-Nevado L, Santiago-Hernandez A, Solanes-Casado S, Gonzalez N, Ricote M, Corton M, Prieto I, Mas S, Sanz AB, Aguilera O, Gomez-Guerrero C, Ayuso C, Ortiz A, Rojo F, Egido J, Garcia-Foncillas J, Minguez P, Alvarez-Llamas G; DiabetesCancerConnect Consortium.

Mol Oncol. 2019 Jun 14. doi: 10.1002/1878-0261.12531. [Epub ahead of print]

2.

Obesity and chronic kidney disease progression-the role of a new adipocytokine: C1q/tumour necrosis factor-related protein-1.

Barbieri D, Goicoechea M, Sánchez-Niño MD, Ortiz A, Verde E, Verdalles U, Pérez de José A, Delgado A, Hurtado E, Sánchez-Cámara L, Lopez-Lazareno N, García-Prieto A, Luño J.

Clin Kidney J. 2018 Oct 11;12(3):420-426. doi: 10.1093/ckj/sfy095. eCollection 2019 Jun.

3.

Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?

Fernandez-Fernandez B, Fernandez-Prado R, Górriz JL, Martinez-Castelao A, Navarro-González JF, Porrini E, Soler MJ, Ortiz A.

Clin Kidney J. 2019 May 31;12(3):313-321. doi: 10.1093/ckj/sfz070. eCollection 2019 Jun.

4.

MAP3K kinases and kidney injury.

Cuarental L, Sucunza-Sáenz D, Valiño-Rivas L, Fernandez-Fernandez B, Sanz AB, Ortiz A, Vaquero JJ, Sanchez-Niño MD.

Nefrologia. 2019 Jun 10. pii: S0211-6995(19)30078-5. doi: 10.1016/j.nefro.2019.03.004. [Epub ahead of print] Review. English, Spanish.

5.

Diagnostic Utility of Exome Sequencing for Kidney Disease.

Carriazo S, Ortiz A, Perez-Gomez MV.

N Engl J Med. 2019 May 23;380(21):2078. doi: 10.1056/NEJMc1903250. No abstract available.

PMID:
31116935
6.

Positive/retained SDHB immunostaining in renal cell carcinomas associated to germline SDHB-deficiency: case report.

Ugarte-Camara M, Fernandez-Prado R, Lorda I, Rossello G, Gonzalez-Enguita C, Cannata-Ortiz P, Ortiz A.

Diagn Pathol. 2019 May 15;14(1):42. doi: 10.1186/s13000-019-0812-6.

7.

Criteria for classification of protein-energy wasting in dialysis patients: impact on prevalence.

Gracia-Iguacel C, González-Parra E, Mahillo I, Ortiz A.

Br J Nutr. 2019 May 14:1-8. doi: 10.1017/S0007114519000400. [Epub ahead of print]

PMID:
31084673
8.

Questioning the Safety of Calcidiol in Hemodialysis Patients.

Villa-Bellosta R, Mahillo-Fernández I, Ortíz A, González-Parra E.

Nutrients. 2019 Apr 26;11(5). pii: E959. doi: 10.3390/nu11050959.

9.

Curcumin reduces renal damage associated with rhabdomyolysis by decreasing ferroptosis-mediated cell death.

Guerrero-Hue M, García-Caballero C, Palomino-Antolín A, Rubio-Navarro A, Vázquez-Carballo C, Herencia C, Martín-Sanchez D, Farré-Alins V, Egea J, Cannata P, Praga M, Ortiz A, Egido J, Sanz AB, Moreno JA.

FASEB J. 2019 Apr 29:fj201900077R. doi: 10.1096/fj.201900077R. [Epub ahead of print]

PMID:
31034781
10.

PGC-1α deficiency causes spontaneous kidney inflammation and increases the severity of nephrotoxic AKI.

Fontecha-Barriuso M, Martín-Sánchez D, Martinez-Moreno JM, Carrasco S, Ruiz-Andrés O, Monsalve M, Sanchez-Ramos C, Gómez MJ, Ruiz-Ortega M, Sánchez-Niño MD, Cannata-Ortiz P, Cabello R, Gonzalez-Enguita C, Ortiz A, Sanz AB.

J Pathol. 2019 Apr 14. doi: 10.1002/path.5282. [Epub ahead of print]

PMID:
30982966
11.

Clarifying the concept of chronic kidney disease for non-nephrologists.

Perez-Gomez MV, Bartsch LA, Castillo-Rodriguez E, Fernandez-Prado R, Fernandez-Fernandez B, Martin-Cleary C, Gracia-Iguacel C, Ortiz A.

Clin Kidney J. 2019 Feb 14;12(2):258-261. doi: 10.1093/ckj/sfz007. eCollection 2019 Apr.

12.

Burden, access and disparities in kidney disease: chronic kidney disease hotspots and progress one step at a time.

Ortiz A.

Clin Kidney J. 2019 Apr 8;12(2):157-159. doi: 10.1093/ckj/sfz026. eCollection 2019 Apr.

13.

NIK as a Druggable Mediator of Tissue Injury.

Valiño-Rivas L, Vaquero JJ, Sucunza D, Gutierrez S, Sanz AB, Fresno M, Ortiz A, Sanchez-Niño MD.

Trends Mol Med. 2019 Apr;25(4):341-360. doi: 10.1016/j.molmed.2019.02.005. Epub 2019 Mar 26. Review.

PMID:
30926358
14.

Pros and cons of antithrombotic therapy in end-stage kidney disease: a 2019 update.

Burlacu A, Genovesi S, Ortiz A, Combe C, Basile C, Schneditz D, van der Sande F, Popa GT, Morosanu C, Covic A.

Nephrol Dial Transplant. 2019 Jun 1;34(6):923-933. doi: 10.1093/ndt/gfz040.

PMID:
30879070
15.

Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients.

Fourdinier O, Schepers E, Metzinger-Le Meuth V, Glorieux G, Liabeuf S, Verbeke F, Vanholder R, Brigant B, Pletinck A, Diouf M, Burtey S, Choukroun G, Massy ZA, Metzinger L; European Uremic Toxin Work Group-EUTox.

Sci Rep. 2019 Mar 14;9(1):4477. doi: 10.1038/s41598-019-41101-8.

16.

Podocyturia: why it may have added value in rare diseases.

Sanchez-Niño MD, Perez-Gomez MV, Valiño-Rivas L, Torra R, Ortiz A.

Clin Kidney J. 2018 Oct 5;12(1):49-52. doi: 10.1093/ckj/sfy081. eCollection 2019 Feb.

PMID:
30863545
17.

Erratum.

Sarafidis P, Ferro CJ, Morales E, Ortiz A, Malyszko J, Hojs R, Khazim K, Ekart R, Valdivielso J, Fouque D, London GM, Massy Z, Ruggenenti P, Porrini E, Wiecek A, Zoccali C, Mallamaci F, Hornum M.

Nephrol Dial Transplant. 2019 Feb 28. pii: gfz047. doi: 10.1093/ndt/gfz047. [Epub ahead of print] No abstract available.

PMID:
30820538
18.

Pentoxifylline for Renal Protection in Diabetic Kidney Disease. A Model of Old Drugs for New Horizons.

Donate-Correa J, Tagua VG, Ferri C, Martín-Núñez E, Hernández-Carballo C, Ureña-Torres P, Ruiz-Ortega M, Ortiz A, Mora-Fernández C, Navarro-González JF.

J Clin Med. 2019 Feb 27;8(3). pii: E287. doi: 10.3390/jcm8030287. Review.

19.

Proteomics for Clinical Assessment of Kidney Disease.

Ortiz A.

Proteomics Clin Appl. 2019 Mar;13(2):e1900004. doi: 10.1002/prca.201900004. Epub 2019 Feb 25.

PMID:
30768767
20.

SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.

Sarafidis P, Ferro CJ, Morales E, Ortiz A, Malyszko J, Hojs R, Khazim K, Ekart R, Valdivielso J, Fouque D, London GM, Massy Z, Ruggenenti P, Porrini E, Wiecek A, Zoccali C, Mallamaci F, Hornum M.

Nephrol Dial Transplant. 2019 Feb 1;34(2):208-230. doi: 10.1093/ndt/gfy407.

PMID:
30753708

Supplemental Content

Loading ...
Support Center